AMPHASTARJPM2025_

J. P. Morgan Healthcare ConferenceJanuary 2025Highly Purified Peptide/ProteinProprietaryInjectables Inhalation IntranasalBiosimilar InterchangeableComplex Generic Combination Products2Forward Looking StatementsThis presentation and the accompanying oral presentation contain forward-looking statements, of Amphastar Pharmaceuticals, Inc. (“Amphastar”, “we”. “our” and that are based on our management’s current expectations and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including, but not limited to, information concerning our business plans and objectives, potential growth opportunities, product development, regulatory approvals, market potential, efficiencies, competitive position, and industry environment, among other statements. All statements in this presentation referenced above that are not historical are forward-looking statements, includ